Refortis生物材料公司扩大了其欧洲临床站点,以提高患者招聘和试验效率。 Regentis Biomaterials expanded its European clinical sites to boost patient recruitment and trial efficiency.

Regentis生物材料公司扩大了其在整个欧洲的临床站点网络,以加强对其进行中的商业和临床方案的支持,目的是加速病人的招募和提高试验效率。 Regentis Biomaterials has expanded its clinical site network across Europe to enhance support for its ongoing commercial and clinical programs, aiming to accelerate patient recruitment and improve trial efficiency. 扩展工作包括与几个欧洲国家的医疗中心建立新的伙伴关系,但具体地点和审判细节没有披露。 The expansion includes new partnerships with medical centers in several European countries, though specific locations and trial details were not disclosed. 这一举动凸显了Regentis对推动该地区生物材料研究与发展的承诺。 The move underscores Regentis’s commitment to advancing its biomaterials research and development in the region.